Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver Disease

Not Applicable

Recruiting

• Conditions: Chronic Hepatitis B Chronic Hepatitis C

• Registration Number: JPRN-UMIN000004431
• Lead Sponsor: Research Program of medical disease field of incurable diseases and cancer «Field of hepatitis related research areas» provided dy the Ministry of Health Labor, and Welfare of Japan.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-10-21
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

Not provided

Exclusion Criteria

* History of alcohol abuse (alcohol intake > 20g/day) * Evidence or history of chronic hepatitis not caused by HBV or HCV * During 6 months before registration to this trial has completed, nucleic acid analogue preparations or interferon therapy was performed. * Pregnant or lactating patients * Contraindications of liver biopsy or liver resection

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Correlative evaluation with liver fibrosis by Real-time Tissue Elastography and histological diagnosis.

Secondary Outcome Measures

Name	Time	Method
Correlative evaluation with liver fibrosis by Real-time Tissue Elastography and serum maker. Correlative evaluation with liver fibrosis by Real-time Tissue Elastography and FibroScan.